SYSTEMIX
SyStemix develops cellular and cell-based gene therapies for cancer, AIDS, and genetic diseases based on the use of isolated, expanded, and gene-modified hematopoietic stem cells. The company is based in Palo Alto, California. SyStemix, Inc. was acquired by Novartis AG. In February 1997, SyStemix completed a merger with Novartis Biotech Holding Corp., an indirect wholly owned subsidiary of Novartis, Inc. Novartis shuttered Systemix in 2000.
SYSTEMIX
Industry:
Biotechnology Genetics Health Care Medical
Founded:
1988-01-01
Address:
Palo Alto, California, United States
Country:
United States
Total Employee:
11+
Status:
Closed
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins Sitelinks Search Box
Founder
